Peptides
US4485101A · kind A · utility
44Cited by
7References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 11, 1983 |
| Grant date | Nov 27, 1984 |
| Priority date | — |
| Expiry date | Oct 11, 2003 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In one aspect, dodecapeptides capable of inhibiting GH, insulin, and glucagon secretion and having the formula EQU N-acetyl-Cys-Lys-Asn-A-Phe-D-Trp-Lys-Thr-Phe-Thr-Ser-B-NH.sub.2 wherein A is Phe or 4-X-Phe wherein X is Cl, Br, or F, and B is Cys or D-Cys; or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.